Tag: oral treatment

oral treatment

Latest News

Celltrion headquarters in Songdo, Incheon [CELLTRION]

Celltrion ends development of inhalable Covid-19 treatment

Celltrion is suspending development an inhalable Covid-19 treatment, the company said Tuesday.

2022.6.28

This image provided by Pfizer shows the company's Covid-19 Paxlovid pills, which will be prescribed in Korea starting Friday. [NEWS1]

Pfizer's Covid pills going to patients on Friday

Covid-19 pills will start being prescribed Friday to patients with weak immune systems and people over 64.

2022.1.12

Most popular

Passengers are entering Incheon International Airport Monday as Korea reported 239 imported Covid-19 cases, recording the second-largest number since the massive virus outbreak from the Navy’s Cheonghae unit destroyer dispatched to the Gulf of Aden in July. [NEWS1]

Omicron projected to become dominant strain by end of month

As more than 10 percent of the week's new Covid-19 cases in Korea were caused by the Omicron strain, President Moon Jae-in urged for a swift decision on fourth vaccine shots, while oral treatments are set to be introduced in Korea this week.

2022.1.10

Yun Woong-sup, right, CEO of Ildong Pharmaceutical, and Isao Teshirogi, CEO of Shionogi, pose for a photo after signing an agreement online to codevelop an oral Covid-19 treatment. [ILDONG PHARMACEUTICAL]

Ildong Pharmaceutical and Shionogi codeveloping Covid pill

Ildong Pharmaceutical signed an agreement with Osaka's Shionogi to codevelop S-217622, an oral Covid-19 treatment candidate.

2021.11.18

A GeneOne Life Science researcher conducts tests to develop a Covid-19 treatment in the company's lab in Gangnam, southern Seoul. [YONHAP]

GeneOne's GLS-1027 approved for Phase 2 clinical trials by the EU

GLS-1027, GeneOne Life Science’s Covid-19 oral treatment candidate, received approval to start Phase 2 clinical trials from the European Medicines Agency (EMA) and Bulgaria, the company said Monday.

2021.11.1

Molnupiravir, an oral Covid-19 treatment that is under development by MSD. [AP/YONHAP]

Biopharmaceutical stocks hammered by Merck's Covid pill news

Game-changing Covid oral treatments being announced by multinationals are knocking the stuffing out of biopharmaceuticals, both those pursuing vaccine strategies and those looking for oral remedies of their own for the virus.

2021.10.11

Workers unload boxes carrying some 94,000 doses of Pfizer's Covid-19 vaccine at Incheon International Airport on Thursday. This is the first batch of a total of 1 million doses of Pfizer vaccines that Britain agreed to send to Korea under a bilateral vaccine swap deal. [YONHAP]

Gov't signs deals for oral Covid-19 treatment

The Korean government said Thursday it is negotiating with pharmaceutical companies to buy more Covid-19 oral medications, in addition to an order for 20,000 courses of an antiviral pill.

2021.10.7

Molnupiravir, an oral antiviral Covid-19 treatment that is under development by MSD, which is known as Merck & Co. in the United States and Canada. [AFP/YONHAP]

Oral treatments are next Holy Grail for Korea and Covid

When swine flu hit the world in 2009, Tamiflu was there to save millions of lives. While Covid-19 has focused attention on development of vaccines, health professionals believe treatments could be almost just as important, especially oral treatments.

2021.9.22

Two daughters hold hands with their father Lee Joo-hwan, 93, at a nursing home in Suwon, Gyeonggi, on Monday. Starting Monday, the government temporarily allowed patients and visitors to meet face-to-face if both are fully vaccinated — part of special virus control measures to be applied for the Chuseok holidays until Sept. 26. [NEWS1]

Gov't promises to pay for pricey Covid pills

The Korean government said Monday it will cover all expenses for Covid-19 oral medication if such a treatment is introduced, which is expected to cost over 900,000 won ($765) per dose.

2021.9.13